Liver tumors and resections

Jean de Ville de Goyet, Jean Bernard Otte

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Short-and long-term outcomes of children with malignancies have improved considerably during the last four decades. According to the review by Ries et al.(1991), the survival rate for cancer cases diagnosed before 15 years of age has improved from around 50% in the early 1970s to 75% a decade later. This favorable trend has been observed not only in hematologic malignancies but also in many solid tumors such as Wilms' tumor and hepatoblastoma. This progress is due to many factors including advances in medical expertise, surgical techniques, and most importantly innovation and refinement of adjuvant chemotherapy. With growing numbers of surviving patients, the long-term side effects of chemotherapy are now viewed with increasing concern and may lead us to reconsider therapeutic strategies in the future, possibly promoting further integration of genetic and tumor markers into tailored management protocols. Children with cancers represent a unique population for studying genetic and environmental mechanisms of cancer etiology, and also genetic factors or tumor markers associated with survival. Identifying mechanisms and/or markers encourages the development of prevention, screening or pre-emptive treatment strategies. However, less is known about children's cancers compared to adults and additional research is necessary; the relatively small number of children with cancer and the lack of co-ordinated studies has led, for too long, to fragmentation and duplication of research effort. Large collaborative trials in pediatric cancer research are a priority.

Original languageEnglish
Title of host publicationPediatric Surgery and Urology: Long-Term Outcomes, Second Edition
PublisherCambridge University Press
Pages799-814
Number of pages16
ISBN (Print)9780511545757, 0521839025, 9780521839020
DOIs
Publication statusPublished - Jan 1 2006

Fingerprint

Liver
Neoplasms
Tumor Biomarkers
Genetic Markers
Research
Hepatoblastoma
Wilms Tumor
Population Genetics
Hematologic Neoplasms
Adjuvant Chemotherapy
Survival Rate
Pediatrics
Drug Therapy
Survival
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

de Ville de Goyet, J., & Otte, J. B. (2006). Liver tumors and resections. In Pediatric Surgery and Urology: Long-Term Outcomes, Second Edition (pp. 799-814). Cambridge University Press. https://doi.org/10.1017/CBO9780511545757.062

Liver tumors and resections. / de Ville de Goyet, Jean; Otte, Jean Bernard.

Pediatric Surgery and Urology: Long-Term Outcomes, Second Edition. Cambridge University Press, 2006. p. 799-814.

Research output: Chapter in Book/Report/Conference proceedingChapter

de Ville de Goyet, J & Otte, JB 2006, Liver tumors and resections. in Pediatric Surgery and Urology: Long-Term Outcomes, Second Edition. Cambridge University Press, pp. 799-814. https://doi.org/10.1017/CBO9780511545757.062
de Ville de Goyet J, Otte JB. Liver tumors and resections. In Pediatric Surgery and Urology: Long-Term Outcomes, Second Edition. Cambridge University Press. 2006. p. 799-814 https://doi.org/10.1017/CBO9780511545757.062
de Ville de Goyet, Jean ; Otte, Jean Bernard. / Liver tumors and resections. Pediatric Surgery and Urology: Long-Term Outcomes, Second Edition. Cambridge University Press, 2006. pp. 799-814
@inbook{c723fdabc71e4f138c851115d233da4b,
title = "Liver tumors and resections",
abstract = "Short-and long-term outcomes of children with malignancies have improved considerably during the last four decades. According to the review by Ries et al.(1991), the survival rate for cancer cases diagnosed before 15 years of age has improved from around 50{\%} in the early 1970s to 75{\%} a decade later. This favorable trend has been observed not only in hematologic malignancies but also in many solid tumors such as Wilms' tumor and hepatoblastoma. This progress is due to many factors including advances in medical expertise, surgical techniques, and most importantly innovation and refinement of adjuvant chemotherapy. With growing numbers of surviving patients, the long-term side effects of chemotherapy are now viewed with increasing concern and may lead us to reconsider therapeutic strategies in the future, possibly promoting further integration of genetic and tumor markers into tailored management protocols. Children with cancers represent a unique population for studying genetic and environmental mechanisms of cancer etiology, and also genetic factors or tumor markers associated with survival. Identifying mechanisms and/or markers encourages the development of prevention, screening or pre-emptive treatment strategies. However, less is known about children's cancers compared to adults and additional research is necessary; the relatively small number of children with cancer and the lack of co-ordinated studies has led, for too long, to fragmentation and duplication of research effort. Large collaborative trials in pediatric cancer research are a priority.",
author = "{de Ville de Goyet}, Jean and Otte, {Jean Bernard}",
year = "2006",
month = "1",
day = "1",
doi = "10.1017/CBO9780511545757.062",
language = "English",
isbn = "9780511545757",
pages = "799--814",
booktitle = "Pediatric Surgery and Urology: Long-Term Outcomes, Second Edition",
publisher = "Cambridge University Press",

}

TY - CHAP

T1 - Liver tumors and resections

AU - de Ville de Goyet, Jean

AU - Otte, Jean Bernard

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Short-and long-term outcomes of children with malignancies have improved considerably during the last four decades. According to the review by Ries et al.(1991), the survival rate for cancer cases diagnosed before 15 years of age has improved from around 50% in the early 1970s to 75% a decade later. This favorable trend has been observed not only in hematologic malignancies but also in many solid tumors such as Wilms' tumor and hepatoblastoma. This progress is due to many factors including advances in medical expertise, surgical techniques, and most importantly innovation and refinement of adjuvant chemotherapy. With growing numbers of surviving patients, the long-term side effects of chemotherapy are now viewed with increasing concern and may lead us to reconsider therapeutic strategies in the future, possibly promoting further integration of genetic and tumor markers into tailored management protocols. Children with cancers represent a unique population for studying genetic and environmental mechanisms of cancer etiology, and also genetic factors or tumor markers associated with survival. Identifying mechanisms and/or markers encourages the development of prevention, screening or pre-emptive treatment strategies. However, less is known about children's cancers compared to adults and additional research is necessary; the relatively small number of children with cancer and the lack of co-ordinated studies has led, for too long, to fragmentation and duplication of research effort. Large collaborative trials in pediatric cancer research are a priority.

AB - Short-and long-term outcomes of children with malignancies have improved considerably during the last four decades. According to the review by Ries et al.(1991), the survival rate for cancer cases diagnosed before 15 years of age has improved from around 50% in the early 1970s to 75% a decade later. This favorable trend has been observed not only in hematologic malignancies but also in many solid tumors such as Wilms' tumor and hepatoblastoma. This progress is due to many factors including advances in medical expertise, surgical techniques, and most importantly innovation and refinement of adjuvant chemotherapy. With growing numbers of surviving patients, the long-term side effects of chemotherapy are now viewed with increasing concern and may lead us to reconsider therapeutic strategies in the future, possibly promoting further integration of genetic and tumor markers into tailored management protocols. Children with cancers represent a unique population for studying genetic and environmental mechanisms of cancer etiology, and also genetic factors or tumor markers associated with survival. Identifying mechanisms and/or markers encourages the development of prevention, screening or pre-emptive treatment strategies. However, less is known about children's cancers compared to adults and additional research is necessary; the relatively small number of children with cancer and the lack of co-ordinated studies has led, for too long, to fragmentation and duplication of research effort. Large collaborative trials in pediatric cancer research are a priority.

UR - http://www.scopus.com/inward/record.url?scp=84927119707&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927119707&partnerID=8YFLogxK

U2 - 10.1017/CBO9780511545757.062

DO - 10.1017/CBO9780511545757.062

M3 - Chapter

AN - SCOPUS:84927119707

SN - 9780511545757

SN - 0521839025

SN - 9780521839020

SP - 799

EP - 814

BT - Pediatric Surgery and Urology: Long-Term Outcomes, Second Edition

PB - Cambridge University Press

ER -